Northwire Canada EditionFriday, July 10, 2026
Sign inSubscribe
Northwire
⌕
ABX 51.91 −0.6% TTS 2.50 +0.0% FCI 0.400 −9.1% GR 0.075 +0.0% AII 22.75 +9.4% TUNG 1.72 +1.8% LGO 1.00 −3.9% EMM 0.080 +0.0% OGN 3.45 +2.1% MSA 6.45 +0.3% SGZ 0.045 +0.0% S 0.160 +33.3% GRSL 0.315 −1.6% DEX 0.395 +2.6% WMS 0.040 +0.0% EMPR 0.830 +1.2% ABX 51.91 −0.6% TTS 2.50 +0.0% FCI 0.400 −9.1% GR 0.075 +0.0% AII 22.75 +9.4% TUNG 1.72 +1.8% LGO 1.00 −3.9% EMM 0.080 +0.0% OGN 3.45 +2.1% MSA 6.45 +0.3% SGZ 0.045 +0.0% S 0.160 +33.3% GRSL 0.315 −1.6% DEX 0.395 +2.6% WMS 0.040 +0.0% EMPR 0.830 +1.2%
Earnings Routine −

Else Nutrition Reports First Quarter 2026 Results Highlighting Significant Improvement in Gross Margin and Reduced Net Loss

Else Nutrition Margins Improve But Liquidity Crunch and TSX Delisting Signal Continued Distress

By The Northwire Desk — AI Analysis May 15, 2026 · 13:44 BABY · 0.045 ELSE NUTRITION HOLDINGS INC. J
Executive Summary
  • Else Nutrition reported Q1 2026 financial results showing a significant improvement in gross margin to 40% from 24% YoY, alongside a substantial reduction in net loss to $0.6M from $3.4M YoY.
  • Revenue declined to $1.5 million for the quarter compared to $2.1 million in Q1 2025, primarily attributed to out-of-stock (OOS) challenges despite operational initiatives.
  • Operating expenses were reduced by 45% year-over-year to $1.2 million, reflecting cost-cutting measures and supply chain optimization.
  • Cash balance as of March 31, 2026, stood at $245 thousand including restricted cash, indicating a tight liquidity position relative to quarterly burn rates.
  • Management is actively pursuing a listing on the Canadian Securities Exchange (CSE) following challenges with its Toronto Stock Exchange (TSX) listing status.
  • The TSX granted a 30-day extension to the delisting date of May 8, 2026, intended to ensure trading continuity while CSE application is processed.
Material Impact
  • Profitability vs. Growth: While gross margin expansion and loss reduction are positive operational indicators, the revenue decline signals that cost-cutting has not yet translated into top-line growth due to supply constraints.
  • Liquidity Risk: The cash position of $245 thousand is critically low given a quarterly net loss of $0.6 million; this implies an immediate need for capital or further operational restructuring to avoid insolvency risks within the next quarter.
  • Exchange Listing Change: The move from TSX to CSE represents a downgrade in market visibility and liquidity access, which may deter institutional investors despite maintaining trading continuity.
  • Operational Consistency: The OOS challenges mentioned align with previous reports (Dec 2025) regarding production funding shortfalls, suggesting the issue is not fully resolved but rather managed through cost reduction.
  • Market Expectation: Given the Nov 2025 financing announcement and Q3 2025 cash position of $91 thousand, investors were already aware of liquidity constraints; thus, this news confirms existing risks rather than introducing a new shock.
BABY · Price
Company Overview
  • Else Nutrition Holdings Inc. is a developer of plant-based infant nutrition products, focusing on non-soy, non-dairy formulas for infants with sensitivities.
  • Flagship projects include the commercialized toddler and kids powder lines (almonds, buckwheat, tapioca) which have surpassed one million cans sold since launch.
  • The core growth driver is the U.S. plant-based infant formula product awaiting FDA clearance under modernized regulatory pathways.
  • The company also maintains a business unit supplying sterile and non-sterile baby bottles and nipples to Israel's largest Health Fund (7% of 2024 revenue).
  • Strategic focus has shifted in 2026 towards direct-to-retail distribution models in Canada following distributor termination in July 2025.
Read the original news release →

More from ELSE NUTRITION HOLDINGS INC. J

Jun 29, 2026 · 07:30

Else Nutrition Announces CSE Conditional Approval

Financings Jun 01, 2026 · 07:45

Else Nutrition Initiates Q2 Manufacturing Drive to Cure Chronic Stockouts as TSX Delisting Looms and CSE Listing Transition Begins

Production / Operations May 07, 2026 · 13:55

Distressed Exchange Transition

Regulatory Apr 15, 2026 · 07:30

Else Nutrition Regulatory Wins Fail to Halt Penny Stock Slide Amid Cash Burn Concerns

Regulatory Mar 10, 2026 · 16:36

Else looks to develop potential infant formula in U.S.

Regulatory Mar 10, 2026 · 07:00

Else Nutrition Expected to Benefit from FDA Regulatory Progress on Infant Formula Protein Standards

Regulatory